Live from the NIH registry
Studies recruiting near Philadelphia right now
Top 25 of 2,149 recruiting studies, sorted by proximity — each links to its official registry page
Nephrotic Syndrome Study Network
Minimal Change Disease (MCD), Membranous Nephropathy
N/A
Observational 1,200 participants sought
Children's Hospital of Philadelphia — Philadelphia, Pennsylvania (4.1 mi)
· Sponsor: University of Michigan
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications
Phase 3
Interventional 115 participants sought
Hospital of the University of Pennsylvania (Adults only) — Philadelphia, Pennsylvania (4.1 mi)
· Sponsor: Pierre Fabre Medicament
CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT
Acute Leukemia, Acute Myeloid Leukemia
N/A
Interventional 50 participants sought
Children's Hospital of Philadelphia — Philadelphia, Pennsylvania (4.1 mi)
· Sponsor: Children's Hospital of Philadelphia
Tocilizumab and Atezolizumab in Adults With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Refractory to 1st Line Immune Checkpoint Inhibitor-Based Therapy
Lung Cancer, Nonsmall Cell
Phase 1, Phase 2
Interventional 28 participants sought
Abramson Cancer Center of the University of Pennsylvania — Philadelphia, Pennsylvania (4.1 mi)
· Sponsor: Abramson Cancer Center at Penn Medicine
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
High Grade Glioma, Diffuse Intrinsic Pontine Glioma
Phase 2
Interventional 120 participants sought
Children's Hospital of Philadelphia — Philadelphia, Pennsylvania (4.1 mi)
· Sponsor: Nationwide Children's Hospital
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
FSGS
Phase 3
Interventional 286 participants sought
The Childrens Hospital of Philadelphia Kohls GI Nutrition and Diagnostic Center — Philadelphia, Pennsylvania (4.1 mi)
· Sponsor: Dimerix Bioscience Pty Ltd
Assessment of Geriatric Evaluations Impact on New AML Guidance
AML, Adult
N/A
Observational 100 participants sought
Abramson Cancer Center at University of Pennsylvania — Philadelphia, Pennsylvania (4.1 mi)
· Sponsor: Abramson Cancer Center at Penn Medicine
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Children's Hospital of Philadelphia — Philadelphia, Pennsylvania (4.1 mi)
· Sponsor: National Cancer Institute (NCI)
Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure
Chronic Lymphocytic Leukaemia, Moderate to Severe Cardiac Impairment
Phase 4
Interventional 60 participants sought
Research Site — Philadelphia, Pennsylvania (4.1 mi)
· Sponsor: AstraZeneca
Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Gonorrhea, Chlamydia
Phase 4
Interventional 760 participants sought
Penn Prevention — Philadelphia, Pennsylvania (4.1 mi)
· Sponsor: Westat
A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory Neuroblastoma
Neuroblastoma Recurrent
Phase 2
Interventional 54 participants sought
Children's Hospital of Philadelphia — Philadelphia, Pennsylvania (4.1 mi)
· Sponsor: St. Jude Children's Research Hospital
A Study of Brenipatide in Participants With Alcohol Use Disorder
Alcohol Use Disorder
Phase 3
Interventional 1,100 participants sought
Penn Medicine: University of Pennsylvania Health System — Philadelphia, Pennsylvania (4.1 mi)
· Sponsor: Eli Lilly and Company
CART123 Cells With or Without Ruxolitinib in Relapsed/Refractory Acute Myeloid Leukemia
Acute Myeloid Leukemia (AML)
Phase 1
Interventional 30 participants sought
Children's Hospital of Philadelphia — Philadelphia, Pennsylvania (4.1 mi)
· Sponsor: Stephan Grupp MD PhD
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Pancreatic Cancer, Pancreatic Cancer Metastatic
Phase 3
Interventional 570 participants sought
Thomas Jefferson University — Philadelphia, Pennsylvania (4.1 mi)
· Sponsor: Immuneering Corporation
A Study to Determine the Effects of ENDS Flavor Availability on Abstinence Within Smokers
Smoking, Tobacco
N/A
Interventional 1,280 participants sought
Sago Philadelphia — Philadelphia, Pennsylvania (4.1 mi)
· Sponsor: RAI Services Company
One-Time DNA Study for Vasculitis
Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Giant Cell Arteritis
N/A
Observational 1,000 participants sought
University of Pennsylvania — Philadelphia, Pennsylvania (4.1 mi)
· Sponsor: University of Pennsylvania
Maternal Cancer Diagnosis and Treatment During Pregnancy:a Database for Maternal, Fetal, and Neonatal Outcomes
Pregnancy, Cancer, Cancer in Pregnancy, Gestational Breast Cancer, Pregnancy Related
N/A
Observational 400 participants sought
Cooper University Hospital — Camden, New Jersey (5.7 mi)
· Sponsor: Cooper Norcross Health
Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma
Folliculotropic Mycosis Fungoides, Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma
Phase 1, Phase 2
Interventional 78 participants sought
Thomas Jefferson University Hospital — Philadelphia, Pennsylvania (4.1 mi)
· Sponsor: City of Hope Medical Center
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
N/A
Observational 20,000 participants sought
University of Pennsylvania, Penn Presbyterian Medical Center — Philadelphia, Pennsylvania (4.1 mi)
· Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
Adaptive Radiation for Abdominopelvic Metastases
Neoplasm - Soft Tissue Pelvis Malignant Secondary, Malignant Neoplasm of Stomach
Phase 1
Interventional 30 participants sought
Fox Chase Cancer Center — Philadelphia, Pennsylvania (4.1 mi)
· Sponsor: Fox Chase Cancer Center
A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-ACM)
PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM)
Phase 1
Interventional 9 participants sought
Children's Hospital of Philadelphia — Philadelphia, Pennsylvania (4.1 mi)
· Sponsor: Rocket Pharmaceuticals Inc.
Reverse-Engineering of Exclusive Enteral Nutrition (RE-EEN) in Crohn's Disease: A Multi-Center Trial
Crohn Disease
N/A
Interventional 60 participants sought
Children's Hospital of Philadelphia — Philadelphia, Pennsylvania (4.1 mi)
· Sponsor: Seattle Children's Hospital
Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Therapy
Chronic Graft-versus-host Disease (cGVHD)
Phase 2
Interventional 120 participants sought
Fox Chase Cancer Center — Philadelphia, Pennsylvania (4.1 mi)
· Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Improving Sleep, Decision-Making, and Eating in Adolescents With Obesity
Adolescent Overweight, Adolescent Obesity
N/A
Interventional 50 participants sought
Nemours Children's Clinic — Wilmington, Delaware (28.4 mi)
· Sponsor: Nemours Children's Clinic
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes
N/A
Observational 200 participants sought
The Children's Hospital of Philadelphia — Philadelphia, Pennsylvania (4.1 mi)
· Sponsor: Jaeb Center for Health Research